Kerry is an associate at Fineberg Ramamoorthy LLP. Kerry practices intellectual property litigation, with a focus on pharmaceutical and biotechnology patent disputes and Patented Medicines (Notice of Compliance) proceedings.

Before joining the firm, Kerry gained broad experience in IP matters at the Toronto office of a global law firm. In 2017, Kerry was seconded to a leading consumer packaged goods company, where she assisted with a range of intellectual property and business needs.

Kerry obtained her J.D. from the University of Toronto. During her studies, Kerry completed an externship at a world-leading not-for-profit drug discovery institution. Kerry was also a senior editor for the University of Toronto Faculty of Law Review and an active member of the Technology and Intellectual Property Group.

Kerry has a technical background in the areas of genetics, molecular biology, and pharmaceutical biotechnology. Kerry earned a M.Sc. from the University of Toronto. Her research focused on developing a novel high-throughput platform to identify lead compounds for drug development. Kerry has also worked as a research associate and has co-authored publications in scientific journals.

  • Called to the Ontario Bar, 2017
  • J.D., University of Toronto
  • M.Sc., Molecular Genetics, University of Toronto
  • B.Sc. (Hons), Biology and Chemistry, University of Ontario Institute of Technology
  • Member of the Canadian Bar Association and Ontario Bar Association
  • Member of the Intellectual Property Institute of Canada (IPIC)
  • Member of the IPIC young practitioners committee